Daniel Yadegar
InvestorCo-Founder and Chief Medical Officer at Newpath Partners · Board director at Rinascera Therapeutics · Board director at DermBiont
Writes $50K – $10M checks
Find your path to Daniel
5 people in our graph share verified history with Daniel — schools, employers, funds. One of them is your warm intro.
About
Daniel Yadegar is a triple board‑certified cardiologist who embeds clinical leadership into fund management as co‑founder and CMO, while leading multiple healthcare platforms, serving on public boards, and practicing clinically.
Invests in
BiotechHealthtechMedical Devices
Board director at Rinascera Therapeutics
Intro paths
In turn, Daniel can intro founders to Rinascera Therapeutics's investors below.
Rinascera Therapeutics's investors · 1
Board director at DermBiont
Intro paths
In turn, Daniel can intro founders to DermBiont's investors below.
DermBiont's investors · 7
Co-founders at DermBiont
Deals · 2
Rinascera TherapeuticsBoard seat
via Newpath Partners · filed Oct 2025 · $2.5M raise
DermBiontBoard seat
via Newpath Partners · filed Nov 2024 · $45.3M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Newpath Partners
Frequently asked questions
- Who is Daniel Yadegar?
- Daniel Yadegar is a triple board‑certified cardiologist who embeds clinical leadership into fund management as co‑founder and CMO, while leading multiple healthcare platforms, serving on public boards, and practicing clinically.
- Where does Daniel Yadegar work?
- Daniel Yadegar is Co-Founder and Chief Medical Officer at Newpath Partners and Board director at Rinascera Therapeutics and Board director at DermBiont.
- What does Daniel Yadegar invest in?
- Daniel Yadegar invests in Biotech, Healthtech, Medical Devices.
- What check size does Daniel Yadegar write?
- Daniel Yadegar typically writes checks of $50K – $10M.
- What boards does Daniel Yadegar sit on?
- Daniel Yadegar holds tracked board seats at DermBiont, Rinascera Therapeutics.